Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Change in Account Payables (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Change in Account Payables for 3 consecutive years, with -$5.9 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 2.5% to -$5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2025, up 289.3% year-over-year, with the annual reading at $3.1 million for FY2025, 289.3% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$5.9 million at Nuvation Bio, up from -$7.1 million in the prior quarter.
  • The five-year high for Change in Account Payables was $11.9 million in Q2 2025, with the low at -$7.1 million in Q3 2025.
  • Average Change in Account Payables over 3 years is $128916.7, with a median of -$184000.0 recorded in 2023.
  • Peak annual rise in Change in Account Payables hit 3614.22% in 2024, while the deepest fall reached 3578.05% in 2024.
  • Over 3 years, Change in Account Payables stood at -$164000.0 in 2023, then crashed by 3578.05% to -$6.0 million in 2024, then rose by 2.5% to -$5.9 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$5.9 million, -$7.1 million, and $11.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.